Morphine modulates γδ lymphocytes cytolytic activity following BCG vaccination

Brain, Behavior, and Immunity

Volumn 21, Issue 2, 2007, Pages 195-201

  Olin, Michael R ^a   Choi, Keumhwa ^a   Lee, Jinhee ^b   Peterson, Phillip K ^c   Molitor, Thomas W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

T lymphocyte; Cytolytic activity; Mycobacteria bovis BCG; NK activity; Opioids

Indexed keywords

BCG VACCINE; MORPHINE; OPIATE; NARCOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL INFECTION; BCG VACCINATION; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; INFECTION SENSITIVITY; MALE; MONOCYTE; MYCOBACTERIUM BOVIS; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; ANIMAL; CYTOTOXICITY TEST; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL;

ANIMALS; BCG VACCINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MORPHINE; MYCOBACTERIUM BOVIS; NARCOTICS; SUS SCROFA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33845932544     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2006.06.003     Document Type: Article

References (63)

1. Anderson J.E., Wilson R.W., Barker P., Doll L., Jones T.S., and Holtgrave D. Prevalence of sexual and drug-related HIV risk behaviors in the US adult population: results of the 1996 national household survey on drug abuse. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 21 (1999) 148-156
2. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.H., and Siegrist C.A. Neonatal and early life immune response to various forms of vaccine antigens differ from adult immune responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 26 (1996) 1489-1495
3. Batoni G., Harris S.R.A., Kallenius G., Svenson S.B., and Wigzell H. γδ and CD4 αβ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts. Clin. Exp. Allergy. 112 (1998) 52-62
4. Bautista E.M., Suarez P., and Molitor T.W. Cell-mediated immunity to porcine reproductive and respiratory syndrome virus in swine. Arch. Virol. 144 (1999) 117-134
5. Bayer B.M., Daussin S., Hernandez M., and Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29 (1990) 369-374
6. Bender B., Davidson B., and Kline R. Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev. Infect. Dis. 10 (1988) 1142-1154
7. Bhargava H.N., Thomas P.T., Thorat S., and House R.V. Effects of morphine tolerance and abstinence on cellular immune function. Brain Res. 642 (1994) 1-10
8. Bolin C., Whipple D., Khanna K., Risdahl J., Peterson P., and Molitor T. Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J. Infect. Dis. 176 (1997) 1559-1566
9. Brown S.M., Stimmel B., Taub R.N., Kochwa S., and Rosenfield R.E. Immunologic dysfunction in heroin addicts. Arch. Intern. Med. 134 (1974) 1001-1006
10. Bryant H.U., Bernton E.W., Kenner J.R., and Holaday J.W. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology 128 (1991) 3253-3258
11. Bussierre J.L., Adler M.W., Rogers T.J., and Eisenstein T.K. Cytokine reversal of morphine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 264 (1993) 591-597
12. Camacho L., Bartholomew N., Joe G., and Simpson D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 86 (1996) 642-654
13. Chang A.B.F., Grimwood K.F., Harvey A.S.F., Rosenfeld J.V., Fracs F., and Olinsky A.F. Central nervous system tuberculosis after resolution of miliary tuberculosis. Pediatr. Infect. Dis. J. 17 (1998) 519-523
14. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E.H., Fineberg V., and Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. J. Am. Med. Assoc. 271 (1994) 698-705
15. Colditz G.A., Berkey C.S., Mosteller F., Brewer T.F., Wilson M.E., Burdick E.H., and Fineberg V. The efficacy of Bacillus-Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96 (1995) 29-34
16. Comstock GW. Epidemiology of tuberculosis. Am. Rev. Respir. Dis. 125 (1982) 8-15
17. Davis L., McIlraith M.J., Paecheo T., Becker B., Adix L.M., Thomas R., Wacholtz M.C., and Lipsky P.E. Assessment of a positive selection technique using an avidin column to isolate human peripheral blood T cell subsets. J. Immunol. Methods 175 (1994) 247-257
18. Donahoe R.M., Nicholson J.K., Madden J.J., Donahoe F., Shafer D.A., Gordon D., Bokos P., and Falek A. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin. Immunol. Immunopathol. 41 (1986) 254-264
19. Donahoe R., and Falek A. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. Adv. Biochem. Psychopharmacol. 44 (1990) 145-158
20. Eisenstein T.K., and Hilburger M.E. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83 (1998) 36-44
21. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Mechanisms whereby macrophage-derived nitric oxide is involved in morphine-induced suppression of splenic lymphocyte proliferation. J. Pharmacol. Exp. Ther. 2 (1995) 477-483
22. Fine P.E. Bacille-Calmette-Guérin vaccines: a rough guide. Clin. Infect. Dis. 20 (1995) 11-14
23. Fischer K., Andreesen R., and Mackensen A. An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J. Immunol. Methods 259 (2002) 159-169
24. Flores L.R., Wahl S.M., and Bayer B.M. Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking. J. Pharmacol. Exp. Ther. 3 (1995) 1246-1251
25. Flynn J., and Chan J. Immunology of tuberculosis. Ann. Rev. Immunol. 19 (2001) 93-129
26. Friedman H. Drugs of abuse as possible co-factors in AIDS progression: summary of panel discussion. Adv. Exp. Med. Biol. 402 (1996) 225-228
27. Gomez-Flores R., and Weber R.J. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. J. Interferon. Cytokine Res. 6 (1999) 625-630
28. Gurwitz D., and Kloog Y. Do endogenous cannabinoids contribute to HIV-mediated immune failure?. Mol. Med. Today 4 (1998) 196-200
29. Henderson R., Watkins S., and Flynn J. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159 (1997) 635-643
30. Inaba K.M., Inaba M., and Naito R.M. Dendritic cell progenitors phagocytose particulates, including Bacillus-Calmette-Guérin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178 (1993) 479-488
31. + T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95 (1998) 270-275
32. Lee J., Choi K., Olin M., Cho S., and Molitor T. γδ T Cells in immunity induced by Mycobacterium bovis Bacillus-Calmette-Guerin vaccination. Infect. Immun. 72 (2004) 1504-1511
33. Lee-MacAry A.E., Ross E.L., Davies D., and Wilkinson R.W. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J. Immunol. Methods 252 (2001) 83-92
34. Li B., Rossman M.D., Imir T., Oner-Eyuboglu A.F., and Carding S.R. Disease-specific changes in γδ T cell repertoire and function in patients with pulmonary tuberculosis. J. Immunol. 157 (1996) 4222-4229
35. Lyadova I., Yeremeev V., Majorov K., Nikonenko B., Khaidukov S., Kondratieva T., Kobets N., and Apt A. An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect. Immun. 66 (1998) 4981-4988
36. Lyman W. Perinatal AIDS: drugs of abuse and transplacental infection. Adv. Exp. Med. Biol. 335 (1993) 211-217
37. Lyons A.B. Analyzing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243 (2000) 147-154
38. MacFarlane A., Meissler J.J., Peng X., Rogers T., Geller E., Adler M., and Eisenstein T.K. Morphine increases susceptibility to oral Salmonella typhimurium infection. J. Infect. Dis. 181 (2000) 1350-1358
39. Maiti D., Bhattacharyya A., and Basu J. Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating bad through a phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 276 (2001) 329-333
40. McCarthy L., Wetzel M., Sliker J., Eisenstein T., and Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62 (2001) 111-123
41. McDonough R.J., Madden J.J., Falek A., Shafer D.A., Pline M., Gordon D., Bokos P., Kuehnle J.C., and Mendelson J. Alteration of lymphocyte-T and null lymphocyte frequencies in the peripheral-blood of human opiate addicts-in vivo evidence for opiate receptor-sites on T-lymphocytes. J. Immunol. 125 (1980) 2539-2543
42. Marchant A., Goetghebuer T., Ota M., Wolfe I., Ceesay S., Groote D., Corrah T., Bennett S., Wheeler J., and Huygen K. Newborns develop a Th1-Type immune response to Mycobacterium bovis Bacillus-Calmette-Guérin vaccination. J. Immunol. 163 (1999) 2249-2255
43. Newell G.R., Mansell P., Spitz M., Reuben J., and Hersh E. Volatile nitrites. Use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome. Am. J. Med. 78 (1985) 811-816
44. Nieman R., Fleming J., Coker R., Harris J.R., and Mitchell D. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS 7 (1993) 705-710
45. Ochshorn M., Novick D.M., and Kreek M.J. Invitro studies of the effect of methadone on natural-killer-cell activity. Israel J. Med. Sci. 26 (1990) 421-425
46. Olin M., Choi K., Lee J., and Molitor T.W. γδ T-lymphocytes cytolytic activity against Mycobacterium tuberculosis analyzed by flow cytometry. J. Immunol. Methods 297 (2005) 1-11
47. Orme I.M. Immunity to mycobacteria. Curr. Opin. Immunol. 5 (1993) 497-502
48. + human γδ T cells. J. Immunol. 148 (1992) 575-583
49. Risdahl J., Peterson P., Chao C.C., Pijoan C., and Molitor T.W. Effects of morphine on the pathogenesis of swine herpesvirus infection. J. Infect. Dis. 167 (1993) 1281-1287
50. Roy S., Balasubramanian S., Sumandeep S., Chaboneau R., Wang J., Melnyk D., Beilman G., Vatassery R., and Barke R. Morphine directs T cells toward Th2 differentiation. Surgery 130 (2001) 304-309
51. Roy S., Charboneau R., and Barke R. Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. J. Neuroimmunol. 1999 (1999) 107-114
52. Schild H., Mavaddat N., Litenberger C., Ehrich E., Davis M., Bluestone J., Matis L., and Draper R. The nature of a major histocompatibility complex recognition by γδ T cells. Cell 76 (1994) 29-37
53. School B., Springer S., and Kaufmann S.H.E. Phosphate is essential for stimulation of V9/V2 T lymphocytes by mycobacterial low molecular weight ligand. Eur. J. Immunol. 24 (1994) 1886-1992
54. + T cells primed for production of Type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67 (1999) 3980-3988
55. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., and Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. USA 83 (1986) 7114-7117
56. Singhal P.C., Sharma P., Kapasi A.A., Reddy K., Franki N., and Gibbons N. Morphine enhances macrophage apoptosis. J. Immunol. 160 (1998) 1889-1893
57. Spada F.M., Grant E.P., Peters P.J., Sugita M., and Brenner M.B. Self-recognition of CD1 by γδ T cells: Implications for innate immunity. J. Exp. Med. 191 (2000) 937-948
58. Szabo I., Rojavin M., Bussiere J., Eisenstein T.K., Alder M.W., and Rojers T.J. Suppression of peritoneal macrophage phagocytes of Candida albicans by opioids. J. Pharmacol. Exp. Ther. 267 (1995) 703-706
59. Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J. Infect. Dis. 188 (2003) 1146-1155
60. Underhill D., Ozinsky A., Smith K., and Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96 14 (1999) 459-463
61. + T lymphocytes. Eur. J. Immunol. 31 (2001) 1531-1538
62. Weber R.J., and Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245 (1989) 188-190
63. Yokota T., Uehara K., and Nomota Y. Intrathecal morphine suppresses NK cell activity following abdominal surgery. Can. J. Anesth. 47 (2000) 303-308